Zelira Therapeutics Ltd has released a press release.
OpenBriefing Recording with Dr Stewart Washer
Filed with ASX ·
6ix hasn’t read this filing yet.
Zelira Therapeutics Ltd. on 6ix
In the deck
Earlier from Zelira Therapeutics
- Reinstatement to Official Quotation - 22 November 2016
- Suspension from Official Quotation
- Prospectus
- Consolidation/Split - GLN
- Successful Completion of Pre-IPO Capital Raise
Later from Zelira Therapeutics
- Zelda expands its Intellectual Property portfolio
- Significant Anti-Cancer Effect Observed in Studies
- Collaboration Agreement with Telethon Kids Institute
- Sleep Disorder Clinical Trials Update
- Zelda to Test Formulations Against Pancreatic Cancer
Follow Zelira Therapeutics into a list and get an email when it puts out news.
Follow Zelira Therapeutics